Search - tctmd.com

Displaying 81 - 100 of 100

Sort: Relevancy | Date

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Daily News

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

L.A. McKeown

December 07, 2020

News Opinion CV Team Dispatch

December 2020 News Roundup

L.A. McKeown

December 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Conference News AHA 2020

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

L.A. McKeown

November 18, 2020

News Daily News

Heart Failure Doubles Risk of Dying From COVID-19

L.A. McKeown

October 30, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Conference News ESC 2020

Dapagliflozin Wins in Patients With CKD

Todd Neale

August 31, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Opinion CV Team Dispatch

August 2020 News Roundup

L.A. McKeown

August 01, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

L.A. McKeown

October 21, 2019

News Conference News HFSA 2019

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

L.A. McKeown

September 23, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

News Conference News ESC 2019

Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis

Yael L. Maxwell

September 12, 2019

News Daily News

DAPA-HF: Dapagliflozin Scores a Win in Heart Failure

Todd Neale

August 20, 2019

News Daily News

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

L.A. McKeown

April 23, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

Advertisement

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

December 2020 News Roundup

TCTMD’s Top 10 Most Popular Stories for November 2020

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

Heart Failure Doubles Risk of Dying From COVID-19

TCTMD’s Top 10 Most Popular Stories for September 2020

Dapagliflozin Wins in Patients With CKD

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

August 2020 News Roundup

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis

DAPA-HF: Dapagliflozin Scores a Win in Heart Failure

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content